These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 18786637)

  • 1. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
    Edison P; Archer HA; Gerhard A; Hinz R; Pavese N; Turkheimer FE; Hammers A; Tai YF; Fox N; Kennedy A; Rossor M; Brooks DJ
    Neurobiol Dis; 2008 Dec; 32(3):412-9. PubMed ID: 18786637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
    Edison P; Archer HA; Hinz R; Hammers A; Pavese N; Tai YF; Hotton G; Cutler D; Fox N; Kennedy A; Rossor M; Brooks DJ
    Neurology; 2007 Feb; 68(7):501-8. PubMed ID: 17065593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early and late peak in microglial activation in Alzheimer's disease trajectory.
    Fan Z; Brooks DJ; Okello A; Edison P
    Brain; 2017 Mar; 140(3):792-803. PubMed ID: 28122877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.
    Wiley CA; Lopresti BJ; Venneti S; Price J; Klunk WE; DeKosky ST; Mathis CA
    Arch Neurol; 2009 Jan; 66(1):60-7. PubMed ID: 19139300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease.
    Parbo P; Ismail R; Hansen KV; Amidi A; Mårup FH; Gottrup H; Brændgaard H; Eriksson BO; Eskildsen SF; Lund TE; Tietze A; Edison P; Pavese N; Stokholm MG; Borghammer P; Hinz R; Aanerud J; Brooks DJ
    Brain; 2017 Jul; 140(7):2002-2011. PubMed ID: 28575151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.
    Okello A; Edison P; Archer HA; Turkheimer FE; Kennedy J; Bullock R; Walker Z; Kennedy A; Fox N; Rossor M; Brooks DJ
    Neurology; 2009 Jan; 72(1):56-62. PubMed ID: 19122031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
    Fan Z; Aman Y; Ahmed I; Chetelat G; Landeau B; Ray Chaudhuri K; Brooks DJ; Edison P
    Alzheimers Dement; 2015 Jun; 11(6):608-21.e7. PubMed ID: 25239737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.
    Parbo P; Madsen LS; Ismail R; Zetterberg H; Blennow K; Eskildsen SF; Vorup-Jensen T; Brooks DJ
    Alzheimers Res Ther; 2020 Jan; 12(1):3. PubMed ID: 31898549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study.
    Schuitemaker A; Kropholler MA; Boellaard R; van der Flier WM; Kloet RW; van der Doef TF; Knol DL; Windhorst AD; Luurtsema G; Barkhof F; Jonker C; Lammertsma AA; Scheltens P; van Berckel BN
    Neurobiol Aging; 2013 Jan; 34(1):128-36. PubMed ID: 22840559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
    Edison P; Carter SF; Rinne JO; Gelosa G; Herholz K; Nordberg A; Brooks DJ; Hinz R
    Neuroimage; 2013 Apr; 70():423-33. PubMed ID: 23261639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
    Kemppainen NM; Aalto S; Wilson IA; Någren K; Helin S; Brück A; Oikonen V; Kailajärvi M; Scheinin M; Viitanen M; Parkkola R; Rinne JO
    Neurology; 2006 Nov; 67(9):1575-80. PubMed ID: 16971697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.
    Okello A; Koivunen J; Edison P; Archer HA; Turkheimer FE; Någren K; Bullock R; Walker Z; Kennedy A; Fox NC; Rossor MN; Rinne JO; Brooks DJ
    Neurology; 2009 Sep; 73(10):754-60. PubMed ID: 19587325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topography of 11C-Pittsburgh compound B uptake in Alzheimer's disease: a voxel-based investigation of cortical and white matter regions.
    Faria DP; Duran FL; Squarzoni P; Coutinho AM; Garcez AT; Santos PP; Brucki SM; de Oliveira MO; Trés ES; Forlenza OV; Nitrini R; Buchpiguel CA; Busatto Filho G
    Braz J Psychiatry; 2019; 41(2):101-111. PubMed ID: 30540022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.
    Raji CA; Becker JT; Tsopelas ND; Price JC; Mathis CA; Saxton JA; Lopresti BJ; Hoge JA; Ziolko SK; DeKosky ST; Klunk WE
    J Neurosci Methods; 2008 Jul; 172(2):277-82. PubMed ID: 18582948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
    Edison P; Ahmed I; Fan Z; Hinz R; Gelosa G; Ray Chaudhuri K; Walker Z; Turkheimer FE; Brooks DJ
    Neuropsychopharmacology; 2013 May; 38(6):938-49. PubMed ID: 23303049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
    Ziolko SK; Weissfeld LA; Klunk WE; Mathis CA; Hoge JA; Lopresti BJ; DeKosky ST; Price JC
    Neuroimage; 2006 Oct; 33(1):94-102. PubMed ID: 16905334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
    Byun BH; Kim BI; Park SY; Ko IO; Lee KC; Kim KM; Kim YK; Lee JY; Bu SH; Kim JH; Chi DY; Ha JH; Lim SM
    Medicine (Baltimore); 2017 Mar; 96(12):e6441. PubMed ID: 28328855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation and Functional Connectivity in Alzheimer's Disease: Interactive Influences on Cognitive Performance.
    Passamonti L; Tsvetanov KA; Jones PS; Bevan-Jones WR; Arnold R; Borchert RJ; Mak E; Su L; O'Brien JT; Rowe JB
    J Neurosci; 2019 Sep; 39(36):7218-7226. PubMed ID: 31320450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.